Magnesium Isoglycyrrhizinate Alleviates Arsenic Trioxide-Induced Cardiotoxicity: Contribution of Nrf2 and TLR4/NF-κB Signaling Pathway

References

• WaalkesMP, LiuJ, WardJM, et al. Mechanisms underlying arsenic carcinogenesis: hypersensitivity of mice exposed to inorganic arsenic during gestation. Toxicology. 2004;198(1–3):31–38. doi:10.1016/j.tox.2004.01.01715138027
   PubMed Web of Science ®Google Scholar
• ChenSC, ChenCC, KuoCY, et al. Elevated risk of hypertension induced by arsenic exposure in Taiwanese rural residents: possible effects of manganese superoxide dismutase (MnSOD) and 8-oxoguanine DNA glycosylase (OGG1) genes. Arch Toxicol. 2012;86(6):869–878. doi:10.1007/s00204-011-0797-822193621
   PubMed Web of Science ®Google Scholar
• RatnaikeRN. Acute and chronic arsenic toxicity. Postgrad Med J. 2003;79(933):391–396. doi:10.1136/pmj.79.933.39112897217
   PubMed Web of Science ®Google Scholar
• LazoG, KantarjianH, EsteyE, et al. Use of arsenic trioxide (As2O3) in the treatment of patients with acute promyelocytic leukemia: the M. D. Anderson experience. Cancer. 2003;97(9):2218–2224. doi:10.1002/cncr.1131412712474
   PubMed Web of Science ®Google Scholar
• AuWY, KwongYL. Arsenic trioxide: safety issues and their management. Acta Pharmacol Sin. 2008;29(3):296–304. doi:10.1111/j.1745-7254.2008.00771.x18298894
   PubMed Web of Science ®Google Scholar
• SoignetSL, FrankelSR, DouerD, et al. United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia. J Clin Oncol. 2001;19(18):3852–3860. doi:10.1200/JCO.2001.19.18.385211559723
   PubMed Web of Science ®Google Scholar
• ShiH, HudsonLG, DingW, et al. Arsenite causes DNA damage in keratinocytes via generation of hydroxyl radicals. Chem Res Toxicol. 2004;17(7):871–878. doi:10.1021/tx049939e15257611
   PubMed Web of Science ®Google Scholar
• ZhaoX, FengT, ChenH, et al. Arsenic trioxide-induced apoptosis in H9c2 cardiomyocytes: implications in cardiotoxicity. Basic Clin Pharmacol Toxicol. 2008;102(5):419–425. doi:10.1111/j.1742-7843.2007.00150.x18346055
   PubMed Web of Science ®Google Scholar
• LiZ, PiaoF, LiuS, et al. Subchronic exposure to arsenic trioxide-induced oxidative DNA damage in kidney tissue of mice. Exp Toxicol Pathol. 2010;62(5):543–547. doi:10.1016/j.etp.2009.07.00319674877
   PubMedGoogle Scholar
• HughesMF, BeckBD, ChenY, et al. Arsenic exposure and toxicology: a historical perspective. Toxicol Sci. 2011;123(2):305–332. doi:10.1093/toxsci/kfr18421750349
   PubMed Web of Science ®Google Scholar
• PiaoF, MaN, HirakuY, et al. Oxidative DNA damage in relation to neurotoxicity in the brain of mice exposed to arsenic at environmentally relevant levels. J Occup Health. 2005;47(5):445–449. doi:10.1539/joh.47.44516230839
   PubMed Web of Science ®Google Scholar
• ShiH, ShiX, LiuKJ. Oxidative mechanism of arsenic toxicity and carcinogenesis. Mol Cell Biochem. 2004;255(1–2):67–78. doi:10.1023/B:MCBI.0000007262.26044.e814971647
   PubMed Web of Science ®Google Scholar
• KesselM, LiuSX, XuA, et al. Arsenic induces oxidative DNA damage in mammalian cells. Mol Cell Biochem. 2002;234-235(1–2):301–308. doi:10.1023/A:101592740614212162448
   PubMed Web of Science ®Google Scholar
• KasparJW, NitureSK, JaiswalAK. Nrf2:INrf2(Keap1) signaling in oxidative stress. Free Radic Biol Med. 2009;47(9):1304–1309. doi:10.1016/j.freeradbiomed.2009.07.03519666107
   PubMed Web of Science ®Google Scholar
• WangM, SunG, WuP, et al. Salvianolic Acid B prevents arsenic trioxide-induced cardiotoxicity in vivo and enhances its anticancer activity in vitro. Evid Based Complement Alternat Med. 2013;2013:759483. doi:10.1155/2013/75948323662152
   PubMed Web of Science ®Google Scholar
• CachofeiroV, GoicocheaM, de VinuesaSG, et al. Oxidative stress and inflammation, a link between chronic kidney disease and cardiovascular disease. Kidney Int Suppl. 2009;111(Suppl):S4–S9. doi:10.1038/ki.2008.516
   Web of Science ®Google Scholar
• CaiSY, ChenJX, LiYS. Dioscin protects against diabetic nephropathy by inhibiting renal inflammation through TLR4/NF-κB pathway in mice. Immunobiology. 2020;225(3):151941. doi:10.1016/j.imbio.2020.15194132359778
   PubMed Web of Science ®Google Scholar
• FrantzS, ErtlG, BauersachsJ. Mechanisms of disease: toll-like receptors in cardiovascular disease. Nat Clin Pract Cardiovasc Med. 2007;4(8):444–454. doi:10.1038/ncpcardio093817653117
   PubMedGoogle Scholar
• JamesTN. Long reflections on the QT interval: the sixth annual Gordon K. Moe Lecture. J Cardiovasc Electrophysiol. 1996;7(8):738–759. doi:10.1111/j.1540-8167.1996.tb00581.x8856464
   PubMed Web of Science ®Google Scholar
• BestPJ, HasdaiD, SangiorgiG, et al. Apoptosis. Basic concepts and implications in coronary artery disease. Arterioscler Thromb Vasc Biol. 1999;19(1):14–22. doi:10.1007/s1001699002299888861
   PubMed Web of Science ®Google Scholar
• ZhaoXY, LiGY, LiuY, et al. Resveratrol protects against arsenic trioxide-induced cardiotoxicity in vitro and in vivo. Br J Pharmacol. 2008;154(1):105–113. doi:10.1038/bjp.2008.8118332854
   PubMed Web of Science ®Google Scholar
• WangX, ZhangH, ChenL, et al. Liquorice, a unique “guide drug” of traditional Chinese medicine: a review of its role in drug interactions. J Ethnopharmacol. 2013;150(3):781–790. doi:10.1016/j.jep.2013.09.05524201019
   PubMed Web of Science ®Google Scholar
• RenJ, WangZG. Pharmacological research on the effect of licorice. J Tradit Chin Med. 1988;8(4):307–309.3073265
   PubMedGoogle Scholar
• WangZJ, RenJ, ZhangR. Immunoregulatory studies on ammonium glycyrrhizinate in mice. Chin J Pharmacol Toxicol. 1990;4:36–38.
   Google Scholar
• OjhaS, GolechhaM, KumariS, et al. Glycyrrhiza glabra protects from myocardial ischemia-reperfusion injury by improving hemodynamic, biochemical, histopathological and ventricular function. Exp Toxicol Pathol. 2013;65(1–2):219–227. doi:10.1016/j.etp.2011.08.01121975080
   PubMedGoogle Scholar
• JiangW, ChenQ, LiP, et al. Magnesium isoglycyrrhizinate attenuates lipopolysaccharide-induced depressive-like behavior in mice. Biomed Pharmacother. 2017;86:177–184. doi:10.1016/j.biopha.2016.12.03327978497
   PubMed Web of Science ®Google Scholar
• BeskinaOA, AbramovA, GabdulkhakovaAG, et al. Possible mechanisms of antioxidant activity of glycyrrhizic acid. Biomed Khim. 2006;52(1):60–68.16739922
   PubMedGoogle Scholar
• ChenKJ, ChenWY, ChenX, et al. Increased elimination of paclitaxel by magnesium isoglycyrrhizinate in epithelial ovarian cancer patients treated with paclitaxel plus cisplatin: a pilot clinical study. Eur J Drug Metab Pharmacokinet. 2014;39(1):25–31. doi:10.1007/s13318-013-0136-y23681836
   PubMed Web of Science ®Google Scholar
• LinY, ZhuJ, ZhangX, et al. Inhibition of cardiomyocytes hypertrophy by resveratrol is associated with amelioration of endoplasmic reticulum stress. Cell Physiol Biochem. 2016;39(2):780–789. doi:10.1159/00044778827467279
   PubMedGoogle Scholar
• MaD, ZhangJ, ZhangY, et al. Inhibition of myocardial hypertrophy by magnesium isoglycyrrhizinate through the TLR4/NF-kappaB signaling pathway in mice. Int Immunopharmacol. 2018;55:237–244. doi:10.1016/j.intimp.2017.12.01929274625
   PubMed Web of Science ®Google Scholar
• ZhaoZ, LiuM, ZhangY, et al. Cardioprotective effect of monoammonium glycyrrhizinate injection against myocardial ischemic injury in vivo and in vitro: involvement of inhibiting oxidative stress and regulating Ca2+ homeostasis by L-type calcium channels. Drug Des Devel Ther. 2020;14:331–346. doi:10.2147/DDDT.S232130
   PubMed Web of Science ®Google Scholar
• LinY, ZhangY, SongQ, et al. Magnesium isoglycyrrhizinate inhibits L-type Ca2+ channels, Ca2+ transients, and contractility but not hERG K+ channels. Arch Pharm Res. 2017;40(10):1135–1145. doi:10.1007/s12272-017-0938-628766238
   PubMed Web of Science ®Google Scholar
• VineethaVP, RaghuKG. An Overview on arsenic trioxide-induced cardiotoxicity. Cardiovasc Toxicol. 2019;19(2):105–119. doi:10.1007/s12012-018-09504-730617460
   PubMed Web of Science ®Google Scholar
• MathewsVV, PaulMV, AbhilashM, et al. Myocardial toxicity of acute promyelocytic leukaemia drug-arsenic trioxide. Eur Rev Med Pharmacol Sci. 2013;17(Suppl1):34–38. doi:10.1038/npp.2012.19123436664
   PubMed Web of Science ®Google Scholar
• AlbiniA, PennesiG, DonatelliF, et al. Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention. J Natl Cancer Inst. 2010;102(1):14–25. doi:10.1093/jnci/djp44020007921
   PubMedGoogle Scholar
• JinW, XueY, XueY, et al. Tannic acid ameliorates arsenic trioxide-induced nephrotoxicity, contribution of NF-kappaB and Nrf2 pathways. Biomed Pharmacother. 2020;126:110047. doi:10.1016/j.biopha.2020.11004732146384
   PubMed Web of Science ®Google Scholar
• HemmatiAA, OlapourS, VarziHN, et al. Ellagic acid protects against arsenic trioxide-induced cardiotoxicity in rat. Hum Exp Toxicol. 2018;37(4):412–419. doi:10.1177/096032711770198628474970
   PubMed Web of Science ®Google Scholar
• BirariLA, MahajanUB, PatilKR, et al. Aloin protects against arsenic trioxide-induced myocardial membrane damage and release of inflammatory cytokines. Naunyn Schmiedebergs Arch Pharmacol. 2020;393(8):1365–1372. doi:10.1007/s00210-020-01833-132025748
   PubMed Web of Science ®Google Scholar
• SchieberM, ChandelNS. ROS function in redox signaling and oxidative stress. Curr Biol. 2014;24(10):R453–462. doi:10.1016/j.cub.2014.03.03424845678
   PubMed Web of Science ®Google Scholar
• ZhaoH, HeY, LiS, et al. Subchronic arsenism-induced oxidative stress and inflammation contribute to apoptosis through mitochondrial and death receptor dependent pathways in chicken immune organs. Oncotarget. 2017;8(25):40327–40344. doi:10.18632/oncotarget.1696028454103
   PubMedGoogle Scholar
• KumarS, YedjouCG, TchounwouPB. Arsenic trioxide induces oxidative stress, DNA damage, and mitochondrial pathway of apoptosis in human leukemia (HL-60) cells. J Exp Clin Cancer Res. 2014;33:42. doi:10.1186/1756-9966-33-4224887205
   PubMed Web of Science ®Google Scholar
• KirkinezosIG, MoraesCT. Reactive oxygen species and mitochondrial diseases. Semin Cell Dev Biol. 2001;12(6):449–457. doi:10.1006/scdb.2001.028211735379
   PubMed Web of Science ®Google Scholar
• BajG, ArnulfoA, DeaglioS, et al. Arsenic trioxide and breast cancer: analysis of the apoptotic, differentiative and immunomodulatory effects. Breast Cancer Res Treat. 2002;73(1):61–73. doi:10.1023/A:101527240182212083632
   PubMed Web of Science ®Google Scholar
• ZhangC, WangF, ZhangY, et al. Celecoxib prevents pressure overload-induced cardiac hypertrophy and dysfunction by inhibiting inflammation, apoptosis and oxidative stress. J Cell Mol Med. 2016;20(1):116–127. doi:10.1111/jcmm.1270926512452
   PubMed Web of Science ®Google Scholar
• FuZJ, LiCM, WangTH, et al. Vascular endothelial growth factor expression and pathological changes in the local tissue of facial hemangiomas following injections with pure alcohol. Oncol Lett. 2015;9(3):1099–1103.25663863
   PubMed Web of Science ®Google Scholar
• YuX, WangZ, ShuZ, et al. Effect and mechanism of sorbus pohuashanensis (Hante) hedl flavonoids protect against arsenic trioxide-induced cardiotoxicity. Biomed Pharmacother. 2017;88:1–10. doi:10.1016/j.biopha.2016.12.13028092839
   PubMed Web of Science ®Google Scholar
• JomovaK, JenisovaZ, FeszterovaM, et al. Arsenic: toxicity, oxidative stress and human disease. J Appl Toxicol. 2011;31(2):95–107. doi:10.1002/jat.164921321970
   PubMed Web of Science ®Google Scholar
• FloraSJ. Arsenic-induced oxidative stress and its reversibility. Free Radic Biol Med. 2011;51(2):257–281. doi:10.1016/j.freeradbiomed.2011.04.00821554949
   PubMed Web of Science ®Google Scholar
• WuZ, ZhangY, SongT, et al. Magnesium isoglycyrrhizinate ameliorates doxorubicin-induced acute cardiac and hepatic toxicity via anti-oxidant and anti-apoptotic mechanisms in mice. Exp Ther Med. 2018;15(1):1005–1012. doi:10.3892/etm.2017.547029399108
   PubMed Web of Science ®Google Scholar
• WangY, ZhangZ, WangX, et al. Amelioration of ethanol-induced hepatitis by magnesium isoglycyrrhizinate through inhibition of neutrophil cell infiltration and oxidative damage. Mediators Inflamm. 2017;2017:1–7. doi:10.1155/2017/3526903
   Web of Science ®Google Scholar
• VargheseMV, ManjuA, AbhilashM, et al. Oxidative stress induced by the chemotherapeutic agent arsenic trioxide. Biotech. 2014;4(4):425–430. doi:10.1007/s13205-013-0170-0
   Web of Science ®Google Scholar
• MuthumaniM, PrabuSM. Silibinin potentially attenuates arsenic-induced oxidative stress mediated cardiotoxicity and dyslipidemia in rats. Cardiovasc Toxicol. 2014;14(1):83–97. doi:10.1007/s12012-013-9227-x24062023
   PubMed Web of Science ®Google Scholar
• HoekstraKA, GodinDV, KurtuJ, et al. Effects of oxidant-induced injury on heme oxygenase and glutathione in cultured aortic endothelial cells from atherosclerosis-susceptible and -resistant Japanese quail. Mol Cell Biochem. 2003;254(1–2):61–71. doi:10.1023/A:102738111064014674683
   PubMed Web of Science ®Google Scholar
• EmadiA, GoreSD. Arsenic trioxide-An old drug rediscovered. Blood Rev. 2010;24(4–5):191–199. doi:10.1016/j.blre.2010.04.00120471733
   PubMed Web of Science ®Google Scholar
• RashidS, AliN, NafeesS, et al. Alleviation of doxorubicin-induced nephrotoxicity and hepatotoxicity by chrysin in Wistar rats. Toxicol Mech Methods. 2013;23(5):337–345. doi:10.1016/j.blre.2010.04.00123256457
   PubMed Web of Science ®Google Scholar
• RashikhA, PillaiKK, AhmadSJ, et al. Aliskiren alleviates doxorubicin-induced nephrotoxicity by inhibiting oxidative stress and podocyte injury. J Renin Angiotensin Aldosterone Syst. 2013;14(1):14–22. doi:10.1177/147032031245998023060472
   PubMed Web of Science ®Google Scholar
• DabakDO, KulogluT, OzercanMR. Effects of vitamin D3 (cholecalciferol) on adriamycin-induced nephrotoxicity. Ren Fail. 2009;31(5):400–405. doi:10.1080/0886022090288302019839841
   PubMed Web of Science ®Google Scholar
• TanSN, SimSP, KhooAS. Potential role of oxidative stress-induced apoptosis in mediating chromosomal rearrangements in nasopharyngeal carcinoma. Cell Biosci. 2016;6:35. doi:10.1186/s13578-016-0103-927231526
   PubMed Web of Science ®Google Scholar
• AkayC, Thomas IiiC, GazittY. Arsenic trioxide and paclitaxel induce apoptosis by different mechanism. Cell Cycle. 2004;3(3):322–332. doi:10.4161/cc.3.3.657
   Web of Science ®Google Scholar
• CalvinoE, EstanMC, SimonGP, et al. Increased apoptotic efficacy of lonidamine plus arsenic trioxide combination in human leukemia cells. Reactive oxygen species generation and defensive protein kinase (MEK/ERK, Akt/mTOR) modulation. Biochem Pharmacol. 2011;82(11):1619–1629. doi:10.1016/j.bcp.2011.08.01721889928
   PubMed Web of Science ®Google Scholar
• YaoP, NusslerA, LiuL, et al. Quercetin protects human hepatocytes from ethanol-derived oxidative stress by inducing heme oxygenase-1 via the MAPK/Nrf2 pathways. J Hepatol. 2007;47(2):253–261. doi:10.1016/j.jhep.2007.02.00817433488
   PubMed Web of Science ®Google Scholar
• LyuJH, KimKH, KimHW, et al. Dangkwisoo-san, an herbal medicinal formula, ameliorates acute lung inflammation via activation of Nrf2 and suppression of NF-kappaB. J Ethnopharmacol. 2012;140(1):107–116. doi:10.1016/j.jep.2011.12.04322230470
   PubMed Web of Science ®Google Scholar
• WuKC, LiuJ, KlaassenCD. Role of Nrf2 in preventing ethanol-induced oxidative stress and lipid accumulation. Toxicol Appl Pharmacol. 2012;262(3):321–329. doi:10.1016/j.taap.2012.05.01022627062
   PubMed Web of Science ®Google Scholar
• JaiswalAK. Nrf2 signaling in coordinated activation of antioxidant gene expression. Free Radic Biol Med. 2004;36(10):1199–1207. doi:10.1016/j.freeradbiomed.2004.02.07415110384
   PubMed Web of Science ®Google Scholar
• LeeYH, KimJH, SongCH, et al. Ethanol extract of ganoderma lucidum augments cellular anti-oxidant defense through activation of Nrf2/HO-1. J Pharmacopuncture. 2016;19(1):59–69. doi:10.3831/KPI.2016.19.00827280051
   PubMedGoogle Scholar
• OyamaJ, BlaisC, LiuX, et al. Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-deficient mice. Circulation. 2004;109(6):784–789. doi:10.1161/01.CIR.0000112575.66565.8414970116
   PubMed Web of Science ®Google Scholar
• SnyderGA, SundbergEJ. Molecular interactions in interleukin and toll-like receptor signaling pathways. Curr Pharm Des. 2014;20(8):1244–1258. doi:10.2174/1381612811319999006923713776
   PubMed Web of Science ®Google Scholar